File:SputnikVEfficacy001.svg

Original file (SVG file, nominally 567 × 714 pixels, file size: 10 KB)

Summary

Description
English: Sputnik V efficacy for different conditions. Data from: Logunov D. Y. et al. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia. The Lancet. V. 397, P. 671-681. doi:10.1016/S0140-6736(21)00234-8
Date
Source Own work
Author V1adis1av

Licensing

I, the copyright holder of this work, hereby publish it under the following license:
w:en:Creative Commons
attribution share alike
This file is licensed under the Creative Commons Attribution-Share Alike 4.0 International license.
You are free:
  • to share – to copy, distribute and transmit the work
  • to remix – to adapt the work
Under the following conditions:
  • attribution – You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  • share alike – If you remix, transform, or build upon the material, you must distribute your contributions under the same or compatible license as the original.

Captions

Sputnik V efficacy for different conditions

Items portrayed in this file

depicts

19 March 2021

File history

Click on a date/time to view the file as it appeared at that time.

Date/TimeThumbnailDimensionsUserComment
current09:15, 9 April 2021Thumbnail for version as of 09:15, 9 April 2021567 × 714 (10 KB)VBLby9Fixed Typo (efficasy -> efficacy)
18:42, 19 March 2021Thumbnail for version as of 18:42, 19 March 2021567 × 714 (10 KB)V1adis1avUploaded own work with UploadWizard

The following page uses this file:

Global file usage

The following other wikis use this file:

Metadata